Clinical Trial Update: Comparative Validation of the Growth Hormone Releasing Hormone and Arginine Test for the Diagnosis of Adult Growth Hormone Deficiency [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing the Growth Hormone Releasing Hormone plus Arginine test for diagnosing adult growth hormone deficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Growth Hormone Deficiency | Phase 3 | Status: COMPLETED